Connect with us

INDUSTRIAL HEMP

The Second Publication Of Cannabis Science Inc (OTCMKTS:CBIS) Highlights The Treatment Of Cancers

Published

on

Cannabis Science Inc (OTCMKTS:CBIS) has pronounced the second publication of its research results which in an elaborate way covers the use of cannabinoids (CBD’s) towards the treatment of a wide range of cancers.

The peer-reviewed research article

Titled “Enhancing the Therapeutic Efficacy of Cancer Treatment with Cannabinoids,” the peer-reviewed research article explores the various ways in which the company can fulfill its goal of treating both the lung and the pancreatic cancers. A person well conversant with the matter but who wanted his identity kept anonymous for reasons best known to him said that the article was published on April 24th in Frontiers in Oncology.

The Cannabis Science’s Chief Medical Officer (CMO) Dr. Allen A. Herman opined, “This second publication reflects our ongoing work and we continue to examine the effect of CBDs with and without radiation therapy on lung and pancreatic cancer. This work will form part of our applications to the U.S. Food and Drug Administration (FDA).”

He added that they were quite pleased about the fact that so far they were doing quite well in line with the expansion of the company’s pharmaceutical development program from farm to bedside.

The performance of the peer-reviewed article

It was in September 2017 that the initial results of the company were published and those were in Frontiers in Oncology. The peer-reviewed article, “Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids”, according to an official working with the company has received a significant number of views. It is said that they might be somewhere around 11,000 times. Basically, it pulls along with a greater number of views than most of the Frontiers’ articles.

It is worth noting that the first article sheds light on drug delivery and also focuses on the innovative strategy which can be entrusted with the transportation of CBDs in a direct way to the various cancer cells with minimal side effects and toxicities that have to this point been hampered by the clinical translation efforts.

The simultaneous targeting of tumor progression at the different levels is a matter that most of the experts think of as a major advantage which is only achievable through the combination of CBDs with other therapies.

Advertisement src="//cdn.bannersnack.com/iframe/embed.js">
Advertisement
Advertisement

Title

INDUSTRIAL HEMP3 months ago

Near-Term Headwinds Hit Scotts Miracle-Gro Co (NYSE:SMG) With A Huge Impact

Bank of America Corp (NYSE:BAC) has disclosed that Scotts Miracle-Gro Co (NYSE:SMG) has lately been experiencing several near term risks....

INDUSTRIAL HEMP3 months ago

Argitek Holdings Inc (OTCMKTS:AGTK) To Focus On Acquisition, Revenues & Profitability In 2018

Argitek Holdings Inc (OTCMKTS:AGTK) recently revealed that in 2018, the company’s main focus will be the acquisition, revenues, and profitability....

INDUSTRIAL HEMP3 months ago

PharmaCyte Biotech Inc (OTCMKTS:PMCB) Completes Pore Size Studies & 29 Tests Useful In Pancreatic Cancer Therapy

PharmaCyte Biotech Inc (OTCMKTS:PMCB) has said that the cells it is planning to use in the clinical trial in patients...

INDUSTRIAL HEMP3 months ago

Puration Inc (OTCMKTS:PURA) To Apply For Canadian Recreational Cannabis Cultivation License; To Give EVERx CBD Sports Water Free Samples

Puration Inc (OTCMKTS:PURA) recently announced that it will be applying for the Canadian recreational cannabis cultivation license. The confirmation came...

INDUSTRIAL HEMP3 months ago

Marijuana Company Of America Inc (OTCMKTS:MCOA)’s JV Completes 10,000 Sq. Ft. Greenhouse Set up; Provides Update on Oregon Project

Marijuana Company Of America Inc (OTCMKTS:MCOA) recently announced that its Joint Venture with Bougainville Ventures Inc. based in Washington has...

INDUSTRIAL HEMP3 months ago

Lifestyle Delivery Systems Inc.(OTCMKTS:LDSYF)’s CSPA Group Inc. Receives 15000 Reveur Units & 300 Liters Distillates’ Purchase Orders In Two Different Deals

Lifestyle Delivery Systems Inc. (OTCMKTS:LDSYF) recently made two big announcements related to the receipt of two open purchase orders to...

INDUSTRIAL HEMP3 months ago

Viaderma Inc (OTCMKTS:VDRM) Provides Update On Its Flagship Product Vitastem; Signs $250,000 Agreement With Vage Nigeria Ltd.

Viaderma Inc (OTCMKTS:VDRM), a publicly traded specialty pharmaceutical company recently announced an update on the sales of its flagship product...

INDUSTRIAL HEMP3 months ago

Plandai Biotechnology Inc (OTCMKTS:PLPL) Phytofare Gaining Traction in International Markets

Plandai Biotechnology Inc (OTCMKTS:PLPL) recently issued an update following the successful launch of its Phytofare® supplement. Plandai Biotechnology is a...

INDUSTRIAL HEMP3 months ago

MassRoots Inc (OTCMKTS:MSRT) Issues 2018 Annual Shareholder Letter

MassRoots Inc (OTCMKTS:MSRT) has issued its 2018 Annual Shareholder Letter highlighting on its recent developments as well as its plans...

INDUSTRIAL HEMP3 months ago

Players Network (OTCMKTS:PNTV) Signs Binding Letter Of Intent To Acquire A 56,000-Square-Foot, Fully Operating Greenhouse Complex

Players Network (OTCMKTS:PNTV), a leading integrated and diversified cannabis holding company has announced that it has signed a binding Letter...

Advertisement
Advertisement
Advertisement